The Use of ATP-MgCl2 in the Treatment of Injury and Shock.

Abstract

In conscious rate and primates, bolus infusion of the entire efficacious dose of ATP-MgCl2 transiently decrease mean blood pressure but there were no long term side effects and there were no mortalities. Moreover, daily administration of the entire efficacious dose of ATP-MgCl2 for a period of three months in rats did not produce any mortality or adverse side effects. ATP-MgCl2 was approved for clinical studies by the Food and Drug Administration of the U.S. Army's and our Human Investigation Committee.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 31, 1983
Accession Number
ADA148651

Entities

People

  • A. E. Baue
  • I. H. Chaudry

Organizations

  • Yale University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anesthesia
  • Arteries
  • Biomedical Research
  • Blood
  • Cardiovascular Physiological Phenomena
  • Cardiovascular System
  • Catheters
  • Chemistry
  • Congestion
  • Health Services
  • Heart Rate
  • Hemorrhage
  • Hemorrhagic Shock
  • Medical Personnel
  • Side Effects
  • Veins
  • Vital Signs

Fields of Study

  • Medicine

Readers

  • Cardiovascular Physiology
  • Public Financial Management and Budgeting